AMARIN Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMARIN, and what generic alternatives to AMARIN drugs are available?
AMARIN has two approved drugs.
There are sixty-three US patents protecting AMARIN drugs.
There are three hundred and fifteen patent family members on AMARIN drugs in forty-six countries and twenty supplementary protection certificates in thirteen countries.
Summary for AMARIN
International Patents: | 315 |
US Patents: | 63 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for AMARIN: | See patent lawsuits for AMARIN |
Drugs and US Patents for AMARIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 11,103,477 | ⤷ Sign Up | ⤷ Sign Up | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 8,410,086 | ⤷ Sign Up | ⤷ Sign Up | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 8,551,521 | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AMARIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | 8,188,146 | ⤷ Sign Up |
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | 8,188,146 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AMARIN drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2013-01-15 |
➤ Subscribe | Capsules | 500 mg | ➤ Subscribe | 2017-08-29 |
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2016-07-26 |
International Patents for AMARIN Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Singapore | 10201913645R | ⤷ Sign Up |
Peru | 20150770 | ⤷ Sign Up |
China | 108096237 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for AMARIN Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2443246 | 21C1046 | France | ⤷ Sign Up | PRODUCT NAME: ICOSAPENT ETHYL; NAT. REGISTRATION NO/DATE: EU/1/20/1524 20210329; FIRST REGISTRATION: - EU/1/20/1524 20210329 |
2022495 | 21C1045 | France | ⤷ Sign Up | PRODUCT NAME: ICOSAPENT ETHYL; REGISTRATION NO/DATE: EU/1/20/1524 20210329 |
2022495 | 122021000058 | Germany | ⤷ Sign Up | PRODUCT NAME: ICOSAPENT-ETHYL; REGISTRATION NO/DATE: EU/1/20/1524 20210326 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.